BROKER FORECASTS
82

Most upside (3 months)

The Most Upside chart above shows the companies potential share price gain (%) (the potential share price increase from the current share to the broker target price)

  Company % change  
  Tissue Regenix Group PLC 372.73  
  Provident Financial PLC 280.11  
  EnQuest Plc 163.92  
  Inmarsat PLC 151.72  
  Pendragon PLC 124.49  
  Verona Pharma PLC 120.26  
  PureTech Health Plc 105.84  
  Serco Group PLC 70.64  
  Babcock International Group PLC 66.01  
  McCarthy Stone Plc 65.05  
  Virgin Money Holdings UK Plc 64.75  
  WPP Group PLC 57.85  
  Capita Group (The) PLC 57.27  
  Oxford BioMedica PLC 54.76  
  Greencore Group PLC 53.69  

Performance Analysis (6 Months)

The performance analysis chart above provides a detailed breakdown of Buy, Sell and Hold recommendations for the selected bank or stockbroker. To see a full explanation of how to use this chart, please visit the performance analysis explanation page.

Recommendation Summary (3 months)

Jefferies International News

  • Drax double-upgraded by Jefferies

    02 May 2017 | Drax Group
    Jefferies International has double-upgraded its investment rating on Drax (LON:DRX) and moved straight to buy (from underperform) on the expectation of an 18.5p dividend. The broker said: "We...
  • Broker views: Banknotes, automotive retailing and publishing

    27 March 2017 | De La Rue
    Banknote printer De La Rue (LON:DLAR) was downgraded to hold (from add) by analysts at Numis, which is says is due to the general lack of news flow since mid-Decmber. The broker commented: "There...
  • Broker views: Soft drinks and packaging

    02 March 2017 | Barr (A G)
    Societe Generale has upgraded its recommendation on AG Barr (LON:BAG) to hold (from sell) on the back of the company's planned reformulation of its soft drinks portfolio ahead of the proposed UK...
  • Broker views: M&S, Avingtrans and Greggs

    28 February 2017 | Marks & Spencer Group
    Jefferies International has double-upgraded its recommendation on Marks & Spencer (LON:MKS) - moving to buy from underperform - as part of its wider look at the UK general retailing sector. It...
  • Vesuvius upgraded by Jefferies

    10 November 2016 | Vesuvius
    Jefferies International has double-upgraded its investment rating on Vesuvius (LON:VSVS) by moving straight to 'buy' (from 'underperform'), stating that the metal flow engineer is doing better than...

Jefferies International Notes